GRI Bio, Inc.

Biotechnology • Healthcare • La Jolla, CA, United States • GRI (NCM)

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

GRI Bio closes $8 million public offering of common stock and warrants - Investing.com

Investing.com • Dec 12

Ascendiant Capital Maintains GRI Bio (GRI) Buy Recommendation - Nasdaq

Nasdaq • Dec 8

GRI touts IPF safety edge, lung function gains amid cash crunch - Fierce Biotech

Fierce Biotech • Dec 11

GRI Bio Announces Closing of $8.0 Million Public Offering - GlobeNewswire

GlobeNewswire • Dec 12

GRI Bio (NASDAQ: GRI) unveils Phase 2a IPF results showing favorable safety and collagen biomarker shifts - Stock Titan

Stock Titan • Dec 10

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has GRI Bio, Inc. had layoffs?

No layoff events have been recorded for GRI Bio, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does GRI Bio, Inc. have?

GRI Bio, Inc. has approximately 3 employees.

What industry is GRI Bio, Inc. in?

GRI Bio, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is GRI Bio, Inc. a publicly traded company?

Yes, GRI Bio, Inc. is publicly traded under the ticker symbol GRI on the NCM. The company has a market capitalization of approximately $0.00 billion.

Where is GRI Bio, Inc. headquartered?

GRI Bio, Inc. is headquartered in La Jolla, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.